Related Experiment Video
Updated: May 22, 2026
05:45
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Integrative subtype discovery in glioblastoma using iCluster
Ronglai Shen1, Qianxing Mo, Nikolaus Schultz
1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America. shenr@mskcc.org
Plos One
|April 28, 2012
Summary
This study introduces a new method for analyzing glioblastoma (GBM) data from The Cancer Genome Atlas (TCGA). It identifies three distinct GBM subtypes by integrating multiple data types, offering a unified framework for cancer subtype discovery.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Large-scale cancer genome projects generate multidimensional data.
- Current methods for cancer subtype discovery often involve separate analyses and manual integration, which can be data-type dependent.
- Discovering new insights from complex, multidimensional cancer data requires advanced analytical approaches.
Purpose of the Study:
- To present an integrative subtype analysis of The Cancer Genome Atlas (TCGA) glioblastoma (GBM) dataset.
- To develop a unified and computationally scalable framework for integrative subtype discovery using multidimensional cancer genomic data.
- To reveal new insights into GBM biology through integrated subtype characterization.
Main Methods:
- Applied an integrative analysis workflow to the TCGA glioblastoma dataset.
- Utilized a unified framework for analyzing multidimensional cancer genomic data.
- Performed integrated subtype characterization to identify distinct tumor subtypes.
Main Results:
- Identified three distinct integrated glioblastoma tumor subtypes.
- Subtype 1: Lacks chr 7 gain/chr 10 loss, enriched for G-CIMP, hypermethylation in brain development genes, Proneural expression.
- Subtype 2: Associated with EGFR amplification, promoter methylation of homeobox/G-protein genes, Classical expression.
- Subtype 3: Characterized by NF1/PTEN alterations, Mesenchymal-like expression profile.
Conclusions:
- The proposed data analysis workflow offers a unified and scalable framework for integrative subtype discovery.
- Integrated subtype characterization provides deeper insights into glioblastoma biology than traditional methods.
- This approach harnesses the full potential of large-scale integrated cancer genomic data for advancing cancer research and therapeutic target discovery.
